Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial

High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment

(2015) Rui-Xia Xu et al.   Journal of Clinical Lipidology

Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With Acute Myocardial Infarction

(2014) Masashi Fujino et al.   AMERICAN JOURNAL OF CARDIOLOGY

Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets

(2014) Peter P. Toth et al.   ATHEROSCLEROSIS

Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: Implications for cardiac outcome

(2014) Robin P.F. Dullaart et al.   ATHEROSCLEROSIS

Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function

(2014) Danijela Trifunovic et al.   Cardiovascular Diabetology

Lipoproteins as Biomarkers and Therapeutic Targets in the Setting of Acute Coronary Syndrome

(2014) Robert S. Rosenson et al.   CIRCULATION RESEARCH

The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol

(2014) Robin P.F. Dullaart et al.   CLINICA CHIMICA ACTA

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

(2014) J.-C. Tardif et al.   EUROPEAN HEART JOURNAL

Insulin resistance and short-term mortality in patients with acute myocardial infarction

(2014) Rafael Sanjuan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes

(2014) Chris P. H. Lexis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research

(2013) Michela Triolo et al.   Biomarkers in Medicine

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

(2013) Samia Mora et al.   CIRCULATION

Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events

(2013) Samia Mora et al.   CIRCULATION

Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice

(2013) S C Gordts et al.   GENE THERAPY

Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program

(2013) R. Goldberg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)

(2013) Paul T. Williams et al.   PLoS One

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

(2013) David Preiss et al.   Lancet Diabetes & Endocrinology

Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study

(2012) Niku Oksala et al.   ANNALS OF MEDICINE

Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial

(2012) Chris P. H. Lexis et al.   CARDIOVASCULAR DRUGS AND THERAPY

Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study

(2012) Sarah Parish et al.   CIRCULATION

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

The role of cardiac magnetic resonance imaging following acute myocardial infarction

(2012) Dennis T. L. Wong et al.   EUROPEAN RADIOLOGY

High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events

(2012) Rachel H. Mackey et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Heparin Administration on Metabolomic Profiles in Samples Obtained During Cardiac Catheterization

(2011) Michael P. Brunner et al.   Circulation-Cardiovascular Genetics

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

(2011) R. S. Rosenson et al.   CLINICAL CHEMISTRY

Clinical implications of discordance between low-density lipoprotein cholesterol and particle number

(2011) James D. Otvos et al.   Journal of Clinical Lipidology

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lipid assessment, metabolic syndrome and coronary heart disease risk

(2010) Benoit J. Arsenault et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Relations of Lipid Concentrations to Heart Failure Incidence

(2009) Raghava S. Velagaleti et al.   CIRCULATION

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women

(2009) Samia Mora et al.   CIRCULATION

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

(2008) J. D. Brunzell et al.   DIABETES CARE